9,092 drug samples 'not of standard quality' in the last three years, JP Nadda
Different measures have been initiated to strengthen the coordination between Central and State government health agencies to improve the drug regulatory infrastructure The Union Health Minister, JP Nadda has updated that out of 2,05,448 drug samples tested from 36 states and union territories in the last three years, 9,092 samples were declared sub-standard, while 271 were found to be...
Login or Register to read the full article
Different measures have been initiated to strengthen the coordination between Central and State government health agencies to improve the drug regulatory infrastructure
The Union Health Minister, JP Nadda has updated that out of 2,05,448 drug samples tested from 36 states and union territories in the last three years, 9,092 samples were declared sub-standard, while 271 were found to be spurious or adulterated.
As reported by PTI
In a written reply to Lok Sabha, Health and Family Welfare Minister JP Nadda said that 2,362 drug samples out of 58,537, 3,028 of 72,712 and 3,702 of 74,199 were found to be of substandard quality in 2012-13, 2013-14 and 2014-15 respectively.
Measures like increase in the number of sanctioned posts in Central Drug Standard Control Organisation (CDSCO), development of IT enabled system for online submission of clinical trial application, development of e-governance module for CDSCO and re-equipping the drug testing laboratories with state-of-art equipment, have been initiated, he added.
The Union Health Minister, JP Nadda has updated that out of 2,05,448 drug samples tested from 36 states and union territories in the last three years, 9,092 samples were declared sub-standard, while 271 were found to be spurious or adulterated.
As reported by PTI
In a written reply to Lok Sabha, Health and Family Welfare Minister JP Nadda said that 2,362 drug samples out of 58,537, 3,028 of 72,712 and 3,702 of 74,199 were found to be of substandard quality in 2012-13, 2013-14 and 2014-15 respectively.
Measures like increase in the number of sanctioned posts in Central Drug Standard Control Organisation (CDSCO), development of IT enabled system for online submission of clinical trial application, development of e-governance module for CDSCO and re-equipping the drug testing laboratories with state-of-art equipment, have been initiated, he added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd